StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Tuesday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Price Performance
NYSE NAVB opened at $0.00 on Tuesday. Navidea Biopharmaceuticals has a 1-year low of $0.00 and a 1-year high of $0.15. The company has a market capitalization of $50,040.00, a P/E ratio of -0.01 and a beta of 1.47. The business has a 50 day moving average price of $0.03 and a 200 day moving average price of $0.04.
Navidea Biopharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Navidea Biopharmaceuticals
- Using the MarketBeat Dividend Tax Calculator
- RXO Shares Surge Following New Acquisition Deal
- Dividend Payout Ratio Calculator
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Health Care Stocks Explained: Why You Might Want to Invest
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.